SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-187149
Filing Date
2013-04-30
Accepted
2013-04-30 16:05:43
Documents
6
Period of Report
2013-06-13
Effectiveness Date
2013-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d523482ddef14a.htm DEF 14A 864799
2 GRAPHIC g523482g06j82.jpg GRAPHIC 31547
3 GRAPHIC g523482g36i66.jpg GRAPHIC 6692
4 GRAPHIC g523482g77k97.jpg GRAPHIC 44006
5 GRAPHIC g523482pc1.jpg GRAPHIC 126362
6 GRAPHIC g523482pc2.jpg GRAPHIC 134035
  Complete submission text file 0001193125-13-187149.txt   1338866
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24006 | Film No.: 13797470
SIC: 2834 Pharmaceutical Preparations